Newland Pharmaceutical announced that the company has received one invention patent certificate and two design patent certificates from the National Intellectual Property Administration. The invention patent is titled "Material Concentration System for Traditional Chinese Medicine Manufacturing and Parameter Judgment and Adjustment Method." The two design patents are for "Packaging Box (Kushen Gel)" and "Packaging Box (Longzhang Oral Rinse)." In the first quarter of 2026, Newland Pharmaceutical achieved revenue of 179 million yuan and net profit attributable to the parent company of 3.5 million yuan.
Guiyang Xintian Pharmaceutical Co LtdNewland Pharmaceutical received three patents (one invention, two design) from the National Intellectual Property Administration.